Source: Annual Congress 2011 - Cystic fibrosis: clinical and laboratory studies
Disease area: Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
I. Dicle Sargin, Y. Gokdemir, R. Ersu, B. Karadag, P. Ay, A. Topuzoglu, C. Cimsit, F. Karakoc (Istanbul, Turkey). Evaluation of disease knowledge in children with cystic fibrosis and their families. Eur Respir J 2011; 38: Suppl. 55, 4302

Member's Comments

No comment yet.

Related content which might interest you: Early determinants of lung disease in children with cystic fibrosis Source: Virtual Congress 2020 – New frontiers in cystic fibrosis imaging and lung physiology Year: 2020 Progression of lung disease detected by MRI and impact of NBS in preschool children with cystic fibrosis Source: International Congress 2019 – Advances in care and monitoring of cystic fibrosis Year: 2019 Early renal involvement in children with cystic fibrosis. Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research Year: 2018 Identifying undiagnosed cystic fibrosis in adults with bronchiectasis Source: Eur Respir Monogr 2018; 81: 29-44 Year: 2018 Cystic fibrosis diagnosis in adulthood as a result of study of relatives within the newborn screening programme Source: International Congress 2015 – Cystic fibrosis: assessment and treatment Year: 2015 A new paradigm for the management of children with cystic fibrosis at home: experiences from a Dutch cystic fibrosis clinic Source: Virtual Congress 2021 – New technologies for the management of children with respiratory diseases Year: 2021 Ergospirometry in children with cystic fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 229s Year: 2003 Prevalence of tracheobronchomalacia in young children with cystic fibrosis Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new aspects of risk factors, treatments and diagnosis Year: 2012 Impact of CFTR modulator use on outcomes in people with severe cystic fibrosis lung disease Source: Eur Respir Rev, 29 (155) 190112; 10.1183/16000617.0112-2019 Year: 2020 The effect of transition from a paediatric to adult cystic fibrosis (CF) centre on clinical status and hospital attendance Source: International Congress 2016 – From pleura to bronchi: new insights Year: 2016 Physical activity for cystic fibrosis: perceptions of people with cystic fibrosis, parents and healthcare professionals Source: ERJ Open Res, 6 (3) 00294-2019; 10.1183/23120541.00294-2019 Year: 2020 Clinical characteristics and disease severity of adults with cystic fibrosis with at least one residual function mutation Source: International Congress 2018 – Cystic fibrosis in adults: current research Year: 2018 Predicting five year outcomes in adults with cystic fibrosis: Developing a predictive scoring model Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013 Polysomnograpgic findings in children with cystic fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 391s Year: 2003 Relations between the sinonasal development and the lung disease in cystic fibrosis patients Source: Eur Respir J 2005; 26: Suppl. 49, 103s Year: 2005 Screening for cystic fibrosis among high risk group patients with chronic lung disease Source: Eur Respir J 2002; 20: Suppl. 38, 340s Year: 2002 Questions of predicting and preventing the progression of pneumofibrosis in children with cystic fibrosis Source: International Congress 2019 – Infection and inflammation in cystic fibrosis Year: 2019 Lung function in children with cystic fibrosis liver disease Source: Virtual Congress 2021 – Cystic fibrosis in children: various aspects Year: 2021 Understanding patients’ experience of living with non-cystic fibrosis bronchiectasis Source: Annual Congress 2013 –Aspects of physiotherapy in various clinical conditions and settings Year: 2013 Lumacaftor/ivacaftor-associated health stabilisation in adults with severe cystic fibrosis Source: ERJ Open Res, 7 (1) 00203-2020; 10.1183/23120541.00203-2020 Year: 2021